Skip to main content

Table 2 Demographics of patient cases

From: Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer

Variable

(n = 36)

Sex

 Male

24 (67 %)

 Female

12 (33 %)

Age, median (IQR)

60.5 (23.2)

Race

 Caucasian

32 (89 %)

 African American

3 (8 %)

 Other

1 (3 %)

Smoking Status

 Former

22 (61 %)

 Current

14 (39 %)

Pack-years, median (IQR)

39.0 (33.7)

Lesion size

 < 2 cm

19 (53 %)

 2 to 3 cm

5 (14 %)

 ≥ 3 cm

7 (19 %)

 Ill-defined infiltrate

5 (14 %)

Lesion location

 Peripheral

18 (50 %)

 Central

7 (19 %)

 Both

10 (28 %)

 Unknown

1 (3 %)

Lung cancer histology

12 (33 %)

 Non-small cell

11 (92 %)

  Adenocarcinoma

8 (73 %)

  Squamous

2 (18 %)

  NSCLC other

1 (9 %)

 Small cell

1 (8 %)

Benign diagnoses

24 (67 %)

 Infection

8 (33 %)

 Resolution or stability

7 (29 %)

 Sarcoidosis

1 (4 %)

 Other

8 (33 %)